Rchr
J-GLOBAL ID：200901058200510689   Update date: Dec. 09, 2024

Takaori-Kondo Akifumi

タカオリ アキフミ | Takaori-Kondo Akifumi
Affiliation and department：
Kyoto University Graduate School of Medicine, Graduate School of Medicine Medicine

About Kyoto University Graduate School of Medicine, Graduate School of Medicine Medicine


Job title： Lecturer
Research field  (4)： Genomics ,  Tumor biology ,  Hematology and oncology ,  Virology
Research keywords  (21)： hematopoietic stem cell transplantation ,  cancer immunotherapy ,  cancer cell biology ,  iPS cell ,  DNA repair ,  cancer genomics ,  hematooncology ,  HTLV-1 ,  ユビキチン ,  APOBEC ,  AIDS ,  HIV-1 ,  レトロウイルス ,  ubiquitin ,  Cytidine deaminase ,  APOBEC ,  Lentiviral Vector ,  Gene Therapy ,  AIDS ,  HIV-1 ,  Retrovirus
Research theme for competitive and other funds  (24)：
  • 2022 - 2025 COVID-19における赤血球結合抗体産生病態解明と細胞外小胞を応用した病態制御
  • 2019 - 2022 Optimizing immunomodulation of hematopoietic stem cell transplantation focusing on allelic polymorphisms of KIRs
  • 2019 - 2022 APOBEC3B-induced genome mutations and its contribution to clonal evolution in cancers
  • 2018 - 2021 Comprehensive enhancer analysis and molecular pathogenesis of leukemia using our novel technology
  • 2014 - 2018 Elucidation of the mechanism by which virus inhibits the function of human anti-virus enzymes and molecular basis of drug discovery
Show all
Papers (454)：
  • Yusuke Toda, Hiroaki Fujita, Koshiki Mino, Takuto Koyama, Seiji Matsuoka, Toshie Kaizuka, Mari Agawa, Shigeyuki Matsumoto, Akiko Idei, Momoko Nishikori, et al. Synergistic involvement of the NZF domains of the LUBAC accessory subunits HOIL-1L and SHARPIN in the regulation of LUBAC function. Cell Death & Disease. 2024. 15. 11
  • Momoko Nakamura, Kazuhisa Chonabayashi, Megumi Narita, Yasuko Matsumura, Misato Nishikawa, Yotaro Ochi, Yasuhito Nannya, Masakatsu Hishizawa, Daichi Inoue, Ruud Delwel, et al. Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs. British journal of haematology. 2024
  • Yutaka Shimazu, Junya Kanda, Teruhito Takakuwa, Yoshiyuki Onda, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, et al. The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients. Annals of hematology. 2024
  • Naokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki, Momoko Nishikori, Chisaki Mizumoto, Junya Kanda, Kouhei Yamashita, Miki Nagao, Akifumi Takaori-Kondo. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy. Clinical and Experimental Medicine. 2024. 24. 1
  • Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients. Cancer immunology, immunotherapy : CII. 2024. 73. 7. 135-135
ｍore...
MISC (268)：
  • Yusuke Kosugi, Yu Kaku, Alfredo A. Hinay, Ziyi Guo, Keiya Uriu, Minoru Kihara, Fumitake Saito, Yoshifumi Uwamino, Jin Kuramochi, Kotaro Shirakawa, et al. Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals. The Lancet Infectious Diseases. 2024. 24. 3. e147-e148
  • 鈴木光太郎, 諫田淳也, 家村知樹, 新井康之, 渡邊瑞希, 島津裕, 北脇年雄, 水本智咲, 山下浩平, 高折晃史. Efficacy of Foscarnet in Preventing HHV6 Encephalitis in Adult Cord Blood Transplantation. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2024. 46th
  • 菱澤方勝, 植田知代子, 岸本渉, 島津弥生, 濱田常義, 中村直和, 鈴木光太郎, 島津裕, 錦織桃子, 高折晃史, et al. CAR-T細胞療法後の再発に臍帯血移植で寛解が維持されたびまん性大細胞型B細胞リンパ腫の一例. 日本輸血細胞治療学会誌. 2024. 70. 1
  • 藤田純三, 牧野文信, 安齋樹, 山口圭史, 淺原時泰, 森口舞子, 永田佳代子, 前田亮太, 白川康太朗, 佐藤桂, et al. SARS-CoV2のSタンパク質とVHH抗体複合体の構造解析. 日本結晶学会年会講演要旨集. 2023. 2023
  • 森 拓人, 越智 陽太郎, 昆 彩奈, 吉里 哲一, 古関 明彦, 依田 成玄, 中川 正宏, 竹田 淳恵, 永田 安伸, 吉田 健一, et al. 骨髄異形成症候群におけるSRSF2変異とSTAG2変異と協調的関係(Cooperative effects of SRSF2 and STAG2 mutations on development of myelodysplastic syndrome and its related disorders). 日本癌学会総会記事. 2022. 81回. IS11-6
ｍore...
Works (1)：
  • HIV-1 Vifを標的とした新規抗HIV-1薬の開発
    2004 -
Education (4)：
  • - 1994 Kyoto University
  • - 1994 Kyoto University Graduate School, Division of Medicine
  • - 1986 Kyoto University Faculty of Medicine
  • - 1986 Kyoto University Faculty of Medicine
Professional career (1)：
  • Doctor (Medicine) (Kyoto University)
Work history (3)：
  • 2010/07 - 現在 Graduate School of Medicine, Kyoto University professor
  • 2008 - - 京都大学医学研究科 講師
  • 2000 - - 京都大学医学研究科 助手
Committee career (5)：
  • 2019/07 - 現在 Scientific Reports -
  • 2005/10 - 現在 - -
  • 2016/10 - -
  • 2010/06 - - -
  • 2009/01 - - -
Awards (2)：
  • 1994 - 日本血液学会奨励賞
  • 1994 - The Japanese Society of Hematology, Young Investigator Award
Association Membership(s) (17)：
日本内科学会 ,  日本ウイルス学会 ,  米国細胞生物学会(The American Society for Cell Biology) ,  日本エイズ学会 ,  日本免疫学会 ,  日本癌学会 ,  日本血液学会 ,  The American Society for Cell Biology ,  The Japanese Society for AIDS Research ,  Japanese Society for Immunology ,  The Japanese Cancer Association ,  The Japanese Society of Hematology ,  European Hematology Association ,  International AIDS Society ,  The Japanese Society of HTLV-1 and Related Diseases ,  The Japan Society for Hematopoietic Cell Transplantation ,  The Japanese Association for Infectious Deaseases
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM